Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
40.74
+0.87 (2.18%)
At close: Aug 13, 2025, 4:00 PM
40.73
-0.01 (-0.02%)
After-hours: Aug 13, 2025, 4:20 PM EDT
Kymera Therapeutics Employees
Kymera Therapeutics had 188 employees as of December 31, 2024. The number of employees increased by 1 or 0.53% compared to the previous year.
Employees
188
Change (1Y)
1
Growth (1Y)
0.53%
Revenue / Employee
$237,824
Profits / Employee
-$1,465,074
Market Cap
2.91B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 188 | 1 | 0.53% |
| Dec 31, 2023 | 187 | 20 | 11.98% |
| Dec 31, 2022 | 167 | 26 | 18.44% |
| Dec 31, 2021 | 141 | 66 | 88.00% |
| Dec 31, 2020 | 75 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
KYMR News
- 1 day ago - The Best Small-Cap Stocks to Buy Now - Kiplinger
- 2 days ago - Kymera Therapeutics, Inc. (KYMR) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 days ago - Kymera Therapeutics Announces Second Quarter 2025 Financial Results and Provides a Business Update - GlobeNewsWire
- 6 weeks ago - Kymera Therapeutics Announces Pricing of $250 Million Public Offering - GlobeNewsWire
- 7 weeks ago - Kymera Therapeutics Announces Proposed Public Offering - GlobeNewsWire
- 7 weeks ago - Gilead signs up to $750 million cancer drug deal with Kymera Therapeutics - Reuters
- 7 weeks ago - Kymera Therapeutics Announces Sanofi IRAK4 Collaboration Update - GlobeNewsWire
- 7 weeks ago - Gilead Sciences and Kymera Therapeutics Enter Into Exclusive Option and License Agreement to Develop Novel Oral Molecular Glue CDK2 Degraders - Business Wire